Defective protein factories in disease: A double-edged sword of cell division

November 29, 2018, KU Leuven
Illustration of a defective ribosome that is producing a protein, the bubbles surrounding it refer to the toxic substances that are released in the cell. Credit: © Laboratory for Disease Mechanisms in Cancer

Ever since the 1960s, the researchers have wondered why some patients who suffer from illnesses resulting from inadequate cell division are much more susceptible to cancer, which is conversely characterized by excessive cell division. This unsolved paradox—also known as Dameshek's Riddle—has puzzled the scientific community for years. The Laboratory for Disease Mechanisms in Cancer in Leuven, Belgium now reports how defective ribosomes can cause both insufficient and excessive cell division.

A number of these diseases are related to defects in the essential cellular protein factories called ribosomes, and are therefore named ribosomopathies. The in ribosomopathy patients do not divide sufficiently, resulting in a very broad spectrum of cellular insufficiency symptoms, from anaemia to growth retardation. While there are treatments for some of these symptoms, the increased likelihood of developing makes these disorders particularly challenging to understand and cure.

The Laboratory for Disease Mechanisms in Cancer in Leuven, Belgium, has now reports the mechanism of how defective ribosomes can cause both insufficient and excessive cell division. "Defects in ribosomes have two consequences for cells. On the one hand, the defective ribosomes make specific kinds of mistakes, which leads to the increased production of the proteins that nourish cancer cells. At the same time, these defects cause a build-up of toxic substances that the cells, forcing them to grow and divide less. The cell suffers from several different kinds of damage, including DNA damage. This in turn causes mutations," explains Professor Kim De Keersmaecker, head of the Laboratory for Disease Mechanisms in Cancer.

In a later, second phase, the cellular balance shifts. "All these mutations will eventually include one that is able to compensate for the cell damage and 'rescue' the cell, allowing cell division to increase. At that point, can take advantage of the high availability of proteins that favour their growth. This opens the floodgates, with ever-increasing cancer protein levels and even better rescuing mutations protecting cells from damage. This allows a tumour to grow in an uncontrolled way."

This study provides a solution to the Dameshek's Riddle with regard to ribosome defects. The discovery of this new paradigm also turns ribosome defects into an attractive target in the fight against cancer, explains De Keersmaecker: "We see these defects both in congenital and non-congenital cancers. And now we also know that ribosome defects can give rise to a whole series of additional cellular defects. In other words, if we can tackle the cause, we can prevent many of the downstream problems. This is the research track we are currently exploring."

Explore further: T-cell leukaemia: Cancer cells take advantage of 'survival protein'

More information: Sergey O. Sulima et al, Ribosomal lesions promote oncogenic mutagenesis., Cancer Research (2018). DOI: 10.1158/0008-5472.CAN-18-1987

Related Stories

T-cell leukaemia: Cancer cells take advantage of 'survival protein'

June 26, 2018
The overproduction of the BCL-2 protein is due to a defect in the ribosome, the protein factory of the cell. This defect is found in 10% of the pediatric patients with T-cell leukaemia.

Aggressive form of leukemia linked to defective 'protein factory'

December 9, 2016
Twenty to forty percent of the patients with the type of leukaemia known as multiple myeloma have a defect in the 'protein factory' of the cell: the ribosome. These patients have a poorer prognosis than patients with intact ...

Defective DNA damage repair leads to chaos in the genome

November 12, 2018
Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now found a cause for frequent catastrophic events in the genetic material of cancer cells that have only been known for a few ...

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Receiving genetic information can change risk

December 11, 2018
Millions of people in the United States alone have submitted their DNA for analysis and received information that not only predicts their risk for disease but, it turns out, in some cases might also have influenced that risk, ...

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

How glial cells develop in the brain from neural precursor cells

December 11, 2018
Two types of cells are active in the brain: nerve cells and glial cells. Glial cells have long been regarded primarily as supportive cells, but researchers increasingly recognize that they play an active role in the communication ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.